NEW YORK, July 29, 2026, 1:00 p.m. EDT
UiPath Inc NYSE:PATH advanced 2.5% to $12.50 during midday trading on Wednesday, extending its four-day recovery to 22.5%. Regular trading hours continued on the New York exchange.
The development occurred in the absence of any recent company statement or SEC filing. The latest updates from UiPath’s official channels were posted on July 15 and July 14. As a result, investors are left to assess valuation ahead of the company’s upcoming growth challenge.
| Security | Wednesday change | Change since July 23 close |
|---|---|---|
| UiPath NYSE:PATH | +2.5% | +22.5% |
| Appian NASDAQ:APPN | +4.6% | +30.3% |
| Pegasystems NASDAQ:PEGA | +3.5% | +17.5% |
| iShares Expanded Tech-Software Sector ETF (NYSEARCA:IGV) | +0.6% | +6.0% |
Live prices were captured just before 1 p.m. EDT. Returns are based on closing prices from July 23.
UiPath’s rebound was smaller than Appian’s but exceeded that of Pegasystems, outperforming the main software fund by roughly 16 percentage points. The trend suggests a focused recovery in automation stocks.
The valuation perspective shifts considering the balance sheet. UiPath reported $1.42 billion in cash and marketable securities as of April 30, representing roughly 21% of its present market capitalization.
An initial estimate adjusted for cash places the valuation at approximately $5.18 billion, which equates to around 2.9 times the midpoint of projected revenue guidance for fiscal 2027.
The valuation continues to be challenged by growth expectations. The company’s forecast for the full year suggests around 10.4% revenue expansion. Revenue for the first quarter rose by 17%.
The adjusted operating-income outlook of $430 million suggests a margin of 24.2%. This figure is roughly 1.2 percentage points higher than in fiscal 2026. Most gains in valuation come from stronger margins rather than increased sales.
Annual recurring revenue, or ARR, is a more precise metric. The second-quarter outlook suggests net new ARR between $28 million and $33 million, nearly matching the $31 million reported in the same quarter last year.
The projected increase would decrease by 33% to 43% compared to the opening quarter. UiPath reported a $49 million gain for that interval.
Chief Executive Daniel Dines stated in May that agentic products were “moving from pilot to production.” Annualized recurring revenue for the first quarter increased by 12% to $1.901 billion. Dollar-based net retention stood at 109%. SEC
Profitability provides investors with additional flexibility. UiPath reported operating income of $28 million under generally accepted accounting principles. Operating cash flow totaled $132 million. Adjusted free cash flow amounted to $130 million.
Share repurchases offer an additional method to boost per-share metrics. UiPath allocated $243.8 million to buybacks in the quarter, amounting to 1.85 times its operating cash flow.
The company acquired 20.4 million shares at a mean price of $11.47. On Wednesday, the shares were trading roughly 9% above that level.
The diluted number of shares dropped 3.8% compared to the same period last year. However, cash and securities decreased to $1.42 billion in April, down from $1.69 billion in January. Acquisition expenditures for the quarter amounted to $149.4 million.
The upcoming report needs to demonstrate that agentic deployments are driving an increase in new ARR. If this is not shown, the recovery will depend more on cash, margins, and share repurchases. There is still no evidence of accelerating demand.
Risks: UiPath notes that ARR and retention levels may vary and are not reliable indicators of future performance. Ongoing share repurchases funded with cash could further diminish its balance-sheet buffer.
